Notable Experience:

Phase I-IV Clinical Trials

Experience Managing the Clinical Trial Continuum

Notable Experience:

Phase I-IV Clinical Trials

As a full service CRO, we can handle all aspects of your Phase I – IV clinical trials. We have managed more than 3700 projects across all phases of clinical development, spanning first-in-human through commercialization.

Whether yours is a small regional or large, global, complex study, we deliver clear guidance, clear data and timely results. Our wide array of therapeutic expertise enables us to address the most demanding drug development challenges. We collaborate with you to develop a better future for patients by bringing our expertise to clinical development through the commitment of our employees.

Our experience includes:

Early Phase

Since 1995, our team of clinical research professionals has routinely managed and delivered many successful Early Phase studies covering a wide range of pharmacokinetic and pharmacodynamic studies across the major therapeutic areas and routes of administration.

Phase II – III

Both new and repeat clients have come to us for Phase II – III studies across all major therapeutic areas, including immunotherapies, oncology and rare and orphan diseases. With our full range of services, you gain end-to-end planning to build quality into your trials from the start, to mitigate risk, gain efficiencies, and optimize performance to meet critical milestones.

Our experienced clinical operations team provides strong site management and enrollment strategies while our medical monitors provide vital oversight with a strong focus on safety. Our teams support multiple software and technology platforms to deliver high quality data and robust biostatistics services, on time and without surprises.

Post Approval

With product approval in hand, a critical phase of the drug development process begins. Post-approval studies are a valuable commercial investment, especially considering payer and regulatory requirements. We understand the distinct nuances in the successful design and implementation of post-approval studies from that of pre-approval development.

Our post-approval support involves deploying project managers and clinical development professionals experienced in delivering services for this unique phase of your program, from consultative design and data collection through robust reporting. We focus on providing specific services designed to support products from the point of approval / marketing authorization through launch and beyond.


Contact Synteract

Tell us how to stay in touch with you: